ETNB long (longer-term play)

NASDAQ:ETNB   89bio, Inc
ETNB long, longer-term play

89bio , Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of innovative therapies for nonalcoholic steatohepatitis (NASH), liver and cardio-metabolic diseases. The company was founded on January 01 , 2018 and is headquartered in San Francisco, CA.

Pre-revenue, early stage company.